• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从肝癌患者中开发原代肝细胞的新方法。

New and effective method to develop primary hepatocytes from liver cancer patients.

机构信息

Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, P.R. China.

Department of Pathology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, P.R. China.

出版信息

Exp Biol Med (Maywood). 2022 Jun;247(11):972-981. doi: 10.1177/15353702221085534. Epub 2022 Apr 26.

DOI:10.1177/15353702221085534
PMID:35470702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9189565/
Abstract

Liver cancer (LC) is one of the most common malignant tumors worldwide. Since the mechanism of LC pathogenesis and metastasis cannot be carried out directly on the human body, it is particularly important to establish human liver cancer cell lines for research . In this study, tissue block adherence method combined with cell clumps digestion method was used to establish primary human hepatocytes (PHHs) with a successful rate of 60% (45/75). Short tandem repeat (STR) analysis proved the cells were derived from its paired tissues. These cells from hepatocellular carcinoma (HCC) expressed NTCP and secreted ALB and AAT as detected by western blot, and expressed hepatocyte-specific membrane protein ASGR1 as detected by flow cytometry. Liver cancer biomarkers like CK7 in ICC (intrahepatic cholangiocarcinoma), AFP, and GPC3 in HCC expressed of different degree as detected by immunohistochemical analysis. These cells displayed typical liver cancer cell morphological characteristics and can passage stably. In conclusion, we developed an effective method to establish PHHs. Further studies are necessary to study if these cells maintaining other liver function and reproduce the physiology of the tumors and how these cells behavior in the drug development.

摘要

肝癌 (LC) 是全球最常见的恶性肿瘤之一。由于不能直接在人体上进行 LC 发病机制和转移的研究,因此建立人肝癌细胞系对于研究非常重要。在本研究中,我们采用组织块贴壁法联合细胞团消化法,成功建立了原代人肝癌细胞 (PHH),成功率为 60%(45/75)。短串联重复序列 (STR) 分析证明这些细胞来源于其配对组织。Western blot 检测表明,这些细胞表达 NTCP 并分泌 ALB 和 AAT,流式细胞术检测表明细胞表达肝特异性膜蛋白 ASGR1。免疫组织化学分析显示 ICC(肝内胆管癌)中的 CK7、HCC 中的 AFP 和 GPC3 等肝癌标志物的表达程度不同。这些细胞呈现出典型的肝癌细胞形态特征,并能稳定传代。总之,我们开发了一种有效的建立 PHH 的方法。进一步的研究需要研究这些细胞是否能维持其他肝脏功能,重现肿瘤的生理学特性,以及这些细胞在药物开发中的行为方式。

相似文献

1
New and effective method to develop primary hepatocytes from liver cancer patients.从肝癌患者中开发原代肝细胞的新方法。
Exp Biol Med (Maywood). 2022 Jun;247(11):972-981. doi: 10.1177/15353702221085534. Epub 2022 Apr 26.
2
Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.磷脂酰肌醇蛋白聚糖-3是人类肝癌中肝细胞癌一个组成部分的有用诊断标志物。
Int J Oncol. 2009 Mar;34(3):649-56. doi: 10.3892/ijo_00000190.
3
Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.Notch2 控制小鼠肝细胞源性胆管癌的形成。
Oncogene. 2018 Jun;37(24):3229-3242. doi: 10.1038/s41388-018-0188-1. Epub 2018 Mar 16.
4
Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.在肝细胞癌合并胆管癌中,肝细胞癌成分和胆管癌成分同时出现肝细胞癌和胆管癌两种表型的表达。
Med Mol Morphol. 2012 Dec;45(1):7-13. doi: 10.1007/s00795-010-0534-z. Epub 2012 Mar 20.
5
Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.原发性肝细胞癌与肝内胆管癌同步双癌:一例报告并文献复习
World J Surg Oncol. 2014 Nov 10;12:337. doi: 10.1186/1477-7819-12-337.
6
Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.用于肝细胞癌和胆管癌鉴别诊断的免疫组化标志物的比较分析
Tumori. 2012 Jul-Aug;98(4):478-84. doi: 10.1177/030089161209800413.
7
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.肝癌细胞起源、分子亚型及其对患者预后的影响。
Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30.
8
Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.胆小管细胞癌的形态计量学和免疫组织化学研究:与非肿瘤性胆小管、小叶间胆管和间隔胆管的比较。
J Hepatobiliary Pancreat Sci. 2012 May;19(3):289-96. doi: 10.1007/s00534-011-0483-5.
9
Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.Glypican-3 在胃肠道和胰腺上皮性肿瘤中的表达。
Hum Pathol. 2013 Apr;44(4):542-50. doi: 10.1016/j.humpath.2012.06.016. Epub 2012 Oct 15.
10
Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.音猬因子蛋白在人肝细胞癌和肝内胆管癌中的差异表达
Pathol Oncol Res. 2015 Sep;21(4):901-8. doi: 10.1007/s12253-015-9918-7. Epub 2015 Mar 5.

引用本文的文献

1
Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models.三维生物打印技术在肝胰胆管癌模型中的最新进展
Front Oncol. 2023 Apr 28;13:1143600. doi: 10.3389/fonc.2023.1143600. eCollection 2023.

本文引用的文献

1
Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells.由诱导多能干细胞衍生的人肝细胞维持培养基提高NTCP表达,增强了NTCP重组HepG2细胞中的HBV感染。
Cell Biosci. 2021 Jul 5;11(1):123. doi: 10.1186/s13578-021-00641-1.
2
Transporter Gene Regulation in Sandwich Cultured Human Hepatocytes Through the Activation of Constitutive Androstane Receptor (CAR) or Aryl Hydrocarbon Receptor (AhR).通过组成型雄甾烷受体(CAR)或芳烃受体(AhR)的激活,在三明治培养的人肝细胞中转运体基因的调控
Front Pharmacol. 2021 Jan 21;11:620197. doi: 10.3389/fphar.2020.620197. eCollection 2020.
3
Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma.术前经动脉化疗栓塞术在 A 级肝硬化合并肝细胞癌的腹腔镜肝切除中的应用。
Langenbecks Arch Surg. 2021 May;406(3):763-771. doi: 10.1007/s00423-020-02056-x. Epub 2021 Jan 7.
4
Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.人胎肝细胞类器官的建立及基于 CRISPR-Cas9 的基因敲入和敲除在人肝来源的类器官培养物中的应用。
Nat Protoc. 2021 Jan;16(1):182-217. doi: 10.1038/s41596-020-00411-2. Epub 2020 Nov 27.
5
Mathematical modeling analysis of hepatic uric acid disposition using human sandwich-cultured hepatocytes.应用人夹心培养肝细胞对肝尿酸处置的数学模型分析。
Drug Metab Pharmacokinet. 2020 Oct;35(5):432-440. doi: 10.1016/j.dmpk.2020.06.006. Epub 2020 Jun 22.
6
Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion.端粒酶抑制作用可降低食管鳞状癌细胞的迁移和侵袭能力。
Oncol Lett. 2020 Sep;20(3):2870-2880. doi: 10.3892/ol.2020.11810. Epub 2020 Jul 3.
7
ASGR1 and Its Enigmatic Relative, CLEC10A.ASGR1 及其神秘的同源物 CLEC10A。
Int J Mol Sci. 2020 Jul 8;21(14):4818. doi: 10.3390/ijms21144818.
8
Response to the Comments on Rimassa et al.: "Systemic Treatment Options in Hepatocellular Carcinoma".对里马萨等人《肝细胞癌的全身治疗选择》评论的回应
Liver Cancer. 2020 Apr;9(2):223-224. doi: 10.1159/000503302. Epub 2019 Oct 22.
9
Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas.核苷(酸)类似物抗病毒治疗对乙肝相关小肝细胞癌患者生存的影响。
Cancer Manag Res. 2019 Sep 17;11:8475-8486. doi: 10.2147/CMAR.S201744. eCollection 2019.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.